Evidence map›Paper›PMID 25502631›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.

Victoria C Wing, Doris E Payer, Sylvain Houle, Tony P George, Isabelle Boileau

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Victoria C WingSchizophrenia Division, Complex Mental Illness Program, and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Doris E Payer1] Research Imaging Centre (RIC), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada [2] Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Sylvain HouleResearch Imaging Centre (RIC), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Tony P George1] Schizophrenia Division, Complex Mental Illness Program, and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada [2] Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Isabelle Boileau1] Research Imaging Centre (RIC), Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada [2] Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Centre for Addiction and Mental Health · CAUniversity of Toronto · CA

Funding

Canadian Institutes of Health Research MOP115145
6 · The paper itself

Abstract

Striatal dopamine (DA) is thought to have a fundamental role in the reinforcing effects of tobacco smoking and nicotine. Microdialysis studies indicate that nicotine also increases DA in extrastriatal brain areas, but much less is known about its role in addiction. High-affinity D2/3 receptor radiotracers permit the measurement of cortical DA in humans using positron emission tomography (PET). [(11)C]FLB-457 PET scans were conducted in 10 nicotine-dependent daily smokers after overnight abstinence and reinstatement of smoking. Voxel-wise [(11)C]-FLB-457-binding potential (BPND) in the frontal lobe, insula, and limbic regions was estimated in the two conditions. Paired t-tests showed BPND values were reduced following smoking (an indirect index of DA release). The overall peak t was located in the cingulate gyrus, which was part of a larger medial cluster (BPND change -12.1±9.4%) and this survived false discovery rate correction for multiple comparisons. Clusters were also identified in the left anterior cingulate cortex/medial frontal gyrus, bilateral prefrontal cortex (PFC), bilateral amygdala, and the left insula. This is the first demonstration of tobacco smoking-induced cortical DA release in humans; it may be the result of both pharmacological (nicotine) and non-pharmacological factors (tobacco cues). Abstinence increased craving but had minimal cognitive effects, thus limiting correlation analyses. However, given that the cingulate cortex, PFC, insula, and amygdala are thought to have important roles in tobacco craving, cognition, and relapse, these associations warrant investigation in a larger sample. [(11)C]FLB-457 PET imaging may represent a useful tool to investigate individual differences in tobacco addiction severity and treatment response.

Indexed as

AdultBrain MappingCarbon RadioisotopesCerebral CortexCravingDopamineDopamine AntagonistsFemaleHumansMalePositron-Emission TomographyPyrrolidinesRadiopharmaceuticalsSalicylamidesSmokingTobacco Use DisorderCarbon RadioisotopesDopamineDopamine AntagonistsFLB 457PyrrolidinesRadiopharmaceuticalsSalicylamides

Identifiers

PMID25502631
PMCPMC4397400
OpenAlexW1992931922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.